Piccart-Gebhart MJ - Search Results

1

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.

Mook S, Schmidt MK, Viale G, Pruneri G, Eekhout I, Floore A, Glas AM, Bogaerts J, Cardoso F, Piccart-Gebhart MJ, Rutgers ET, Van't Veer LJ; TRANSBIG Consortium. Mook S, et al. Breast Cancer Res Treat. 2009 Jul;116(2):295-302. doi: 10.1007/s10549-008-0130-2. Epub 2008 Jul 27. Breast Cancer Res Treat. 2009. PMID: 18661261

2

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

de Azambuja E, Cardoso F, de Castro G Jr, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M. de Azambuja E, et al. Br J Cancer. 2007 May 21;96(10):1504-13. doi: 10.1038/sj.bjc.6603756. Epub 2007 Apr 24. Br J Cancer. 2007. PMID: 17453008 Free PMC article.

3

Molecular targeted therapies in breast cancer: where are we now?

Widakowich C, de Azambuja E, Gil T, Cardoso F, Dinh P, Awada A, Piccart-Gebhart M. Widakowich C, et al. Int J Biochem Cell Biol. 2007;39(7-8):1375-87. doi: 10.1016/j.biocel.2007.04.015. Epub 2007 May 4. Int J Biochem Cell Biol. 2007. PMID: 17543572 Review.

4

Individualization of therapy using Mammaprint: from development to the MINDACT Trial.

Mook S, Van't Veer LJ, Rutgers EJ, Piccart-Gebhart MJ, Cardoso F. Mook S, et al. Cancer Genomics Proteomics. 2007 May-Jun;4(3):147-55. Cancer Genomics Proteomics. 2007. PMID: 17878518 Free article. Review.

5

Clinical application of the 70-gene profile: the MINDACT trial.

Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ. Cardoso F, et al. J Clin Oncol. 2008 Feb 10;26(5):729-35. doi: 10.1200/JCO.2007.14.3222. J Clin Oncol. 2008. PMID: 18258980

6

New tools for assessing breast cancer recurrence.

Dinh P, Cardoso F, Sotiriou C, Piccart-Gebhart MJ. Dinh P, et al. Cancer Treat Res. 2008;141:99-118. doi: 10.1007/978-0-387-73161-2_7. Cancer Treat Res. 2008. PMID: 18274085 Review. No abstract available.

7

[The new generation of breast cancer clinical trials: the right drug for the right target].

de Azambuja E, Cardoso F, Meirsman L, Straehle C, Dolci S, Vantongelen K, Piccart-Gebhart M. de Azambuja E, et al. Bull Cancer. 2008 Mar;95(3):352-7. doi: 10.1684/bdc.2008.0587. Bull Cancer. 2008. PMID: 18390416 Free article. Review. French.

8

Facts and controversies in the use of trastuzumab in the adjuvant setting.

Dinh P, de Azambuja E, Cardoso F, Piccart-Gebhart MJ. Dinh P, et al. Nat Clin Pract Oncol. 2008 Nov;5(11):645-54. doi: 10.1038/ncponc1219. Epub 2008 Sep 9. Nat Clin Pract Oncol. 2008. PMID: 18779850 Review.

9

Better translation from bench to bedside: breakthroughs in the individualized treatment of cancer.

Straehle C, Cardoso F, Azambuja E, Dolci S, Meirsman L, Vantongelen K, Ignatiadis M, Sotiriou C, Piccart-Gebhart MJ. Straehle C, et al. Crit Care Med. 2009 Jan;37(1 Suppl):S22-9. doi: 10.1097/CCM.0b013e3181921598. Crit Care Med. 2009. PMID: 19104222

10

Stemming resistance to HER-2 targeted therapy.

Bedard PL, Cardoso F, Piccart-Gebhart MJ. Bedard PL, et al. J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):55-66. doi: 10.1007/s10911-009-9116-x. Epub 2009 Mar 4. J Mammary Gland Biol Neoplasia. 2009. PMID: 19259796 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page